CORAL GABLES, FL / ACCESSWIRE / February 21, 2019 / The recent success of the healthcare stock market can be attributed to the fact that companies in the healthcare industry are looking into new innovative approaches and technologies to better improve their offerings for consumers. Whereas cannabis was previously condemned as a harmful substance, medical experts have released studies showing that medicinal cannabis can be used to reduce inflammation caused by inflammatory diseases, as well as help patients suffering from acute anxiety, and countless other uses. In addition to the medical field shifting towards accepting medicinal cannabis, the healthcare sector, overall, has placed more emphasis on investing in the patient and their quality of life. If these trends continue, companies in the healthcare industry could see an influx of investors looking for lucrative opportunities. Premier Health Group (OTC:PHGRF) (CSE:PHGI), Immune Design Corp (IMDZ), Valeritas Holdings Inc (VLRX), and Aphria Inc (NYSE:APHA) represent four healthcare companies determined to advance their industry into the future.
Premier Health Group (OTC:PHGRF) (CSE:PHGI), like many other companies in healthcare, was created to help people access treatment and care solutions to enable them to live happier, healthier lives. Where Premier stands out from the group is in their unrelenting focus to invest and develop innovative approaches that combine human skill-based expertise with state-of-the-art technologies used throughout the healthcare industry to create the best-possible care solutions for their growing patient network.
Premier Health Group (OTC:PHGRF) (CSE:PHGI), and its executive leadership team have pulled out all of the stops this past year to invest in collaborative partnerships, strategic acquisitions, and further develop plans for expansion, all with their patients best interests at the forefront. In light of all these exciting milestones, the Company provided investors with a corporate update at the tail-end of last week.
Premier Health Group (OTC:PHGRF) (CSE:PHGI) successfully acquired Cloud Practice Inc., a healthcare technology company that provides cloud-based electronic medical records software applications for physicians throughout Canada. Cloud Practice's suite of products includes Juno EMR, a cloud-based EMR solution; ClinicAid, a medical billing software; and MyHealthAccess, an online patient portal. With this acquisition, Premier now has a collective ecosystem of over 3,000,000 active patients and 287 primary care clinics.
In an attempt to focus their expansion efforts into global markets, Premier Health Group (OTC:PHGRF) (CSE:PHGI) recently announced a partnership with a major online healthcare company in China, 360 Health. The parent company, 360 Security Technology, is a leading online service company in China with a market capitalization of over $20 billion USD as of February 14, 2019. This provides an opportunity for our team of health care providers to play an essential role in providing general practitioner training virtually and on-site through medical seminars.
Immune Design Corp (IMDZ), a late-stage immunotherapy company, today announced that they have entered into a definitive agreement with Merck, under which Merck, through a subsidiary, will acquire Immune Design for $5.85 per share in cash for an approximate value of $300 million.
In response to the announcement, Dr. Carlos Paya, President, and CEO of Immune Design said, "Merck has a rich history of discovery and innovation and a strong track record of developing meaningful therapeutics and vaccines. We believe this agreement creates shareholder value by positioning our technologies and capabilities for long-term success with a leading, research-driven biopharmaceutical company."
Valeritas Holdings Inc (VLRX), a medical technology company and maker of V-Go® Wearable Insulin Delivery device, today announced positive clinical outcomes for V-Go compared to insulin pen devices for treating people with type 2 diabetes prescribed basal-bolus insulin therapy. Per the results, at the third and seventh month of V-Go use, patients experienced statistically significant reductions in both A1c levels and total daily doses of insulin. A1c levels decreased by 1.04 and 1.11, respectively from a baseline A1c of 9.1%. The average total daily dose of insulin decreased by 25 and 24 units per day, respectively from a baseline dose of 82 units per day.
John Timberlake, President, and CEO of Valeritas commented, "we are excited to share these positive data from our clinical study at ATTD 2019. We believe the results of this study further support when basal-bolus insulin therapy is needed, the use of V-Go Wearable Insulin Delivery device can offer significant clinical benefit."
Aphria Inc (APHA) made headlines earlier this week when the Company announced that independent members of its Board of Directors unanimously approved the early termination and liquidation of a promissory note, option and other agreements related to the Company's divestment of all interests in Liberty Health Sciences, Inc.
Per the specific details from the Board of Directors meeting, the independent members of the Board of Directors unanimously approved the Early Termination and Liquidation wherein the Company received cash consideration of $47.4 million and may earn up to an additional $10 million based on certain value thresholds, if the counter-parties monetize the Liberty shares underlying the terminated option within six months.
What Is Stock Price (StockPrice.com)?
Stock Price is defined as the price of a single share of a number of saleable stocks of a public company. A stock price is the highest amount an investor or trader is willing to pay for the stock, or the lowest amount that it can be bought for.
StockPrice.com was created for everyone that wants the latest stock quotes, stock charts, company news, and the best financial content.
At Stock Price (StockPrice.com), you get free stock quotes, up-to-date news, international market data, social interaction and the best financial content that will help you manage your financial life.
Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. JSG Communications, LLC which owns www.StockPrice.com is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release.
JSG Communications, LLC, which owns www.StockPrice.com, may from time to time have a position in the securities mentioned herein and may increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice. JSG Communications, LLC, which owns www.StockPrice.com, may be compensated for its services in the form of cash-based compensation or equity securities in the companies it writes about, or a combination of the two.
Pursuant to an agreement between MIDAM VENTURES, LLC and Premier Health Group Inc. we were hired for a period from 10/1/2018 - 4/1/2019 to publicly disseminate information about Premier Health Group Inc. including on the Website and other media including Facebook and Twitter. We were paid $300,000 ( CASH) for & were paid "500,000" shares of restricted common shares (as of 1/2/2019). We own zero shares of Premier Health Group Inc., which we purchased in the open market. Once the (6) Six-month restriction is complete on 4/1/2019 we plan to sell the "500,000" shares of Premier Health Group Inc. that we hold currently in restricted form during the time the Website and/or Facebook and Twitter Information recommends that investors or visitors to the website purchase without further notice to you. We may buy or sell additional shares of Premier Health Group Inc. in the open market at any time, including before, during or after the Website and Information, provide public dissemination of favorable Information. Please click here for full disclaimer.
View source version on accesswire.com: